The German Research Foundation has approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote the further study of the interrelations between the immune system and cardiovascular system disorders. The main focus of the current research project is on the pathogenesis of high blood pressure and arteriosclerosis.
PD Dr. Philip Wenzel, cardiologist and senior physician at the Department of Internal Medicine II, will use the about EUR 300,000 he has been granted for the next 36 months for staff resources and consumables. "We want to pursue the fascinating question of how the blood pressure hormone angiotensin II and the mediators of inflammation, in particular interferon gamma, interact in the pathogenesis of vascular diseases," said Wenzel.
In recent years, it has become increasingly clear that inflammatory cells, which are normally responsible for defending the body against pathogens, are also involved in the development of such frequently encountered disorders as hypertension, heart attack, stroke, and so-called 'window shopping syndrome' or intermittent claudication.
It is possible that many of the medications used to treat these illnesses, such as statins and ACE inhibitors, are only as effective as they are because they actually moderate these inflammatory processes. "Through our research, we hope to establish the foundations on which targeted anti-inflammatory therapies for arteriosclerosis can be developed and used in the future," Wenzel continued.
The successful acquisition of third-party funds is also attributable to the strategy adopted by the University Medical Center of Johannes Gutenberg University Mainz (JGU), namely that of establishing specialized research units. Within this context, the research team led by PD Dr. Philip Wenzel has managed to form partnerships that are important for the future of translational medicine.
"The work of the Research Unit Vascular Prevention and the establishment of the Center for Thrombosis and Hemostasis (CTH) with the support of the Mainz Heart Foundation have created an environment in which applications to the German Research Foundation have a greater chance of success," said Professor Dr. Thomas Münzel, Founding Director of the CTH and Coordinator of the Research Unit Vascular Prevention at the Mainz University Medical Center.
Petra Giegerich | idw
The quest for the oldest ice on Earth
14.11.2016 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung
Empa Innovation Award for new flame retardant
09.11.2016 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Materials Sciences
08.12.2016 | Materials Sciences
08.12.2016 | Physics and Astronomy